ElevateBio
PrivateLast Round
Series D
May 24, 2023
Total Funding Raised
$1.25B
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ElevateBio is a biotechnology company that provides an integrated platform for the discovery, development, and manufacturing of cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ElevateBio Comparables
Compare ElevateBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RoslinCT | 85% | |
| Resilience | 83% | |
| GeneFab | 81% |
ElevateBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 24, 2023 | ||||
| Series C | Mar 15, 2021 | ||||
| Series B | Mar 30, 2020 | ||||
| Series A | May 13, 2019 |
Key People
Founding team and executive leadership
ElevateBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series B, Series A, Series D, Series C |
| Redmile Group | Series B, Series A, Series D, Series C |
| MPM Capital | Series B, Series D, Series C, Series A |
| SoftBank Investment Advisers | Series D, Series C |
| Fidelity Management & Research Company | Series D, Series C |
| MPM BioImpact | Series A, Series B, Series D, Series C |
| SoftBank Group | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 51% MoM.
- Jan 5, 2026
Christopher Murphy named Chief Executive Officer and Board member.
ElevateBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ElevateBio's valuation, stock price, and market status.
Is ElevateBio a public or private company?
ElevateBio is a private company.
What is the current stock price of ElevateBio?
ElevateBio is a private company with no public stock price. No recent secondary market data is available.
How much is ElevateBio worth (valuation)?
Valuation information for ElevateBio is not publicly available.
Can I buy ElevateBio stock?
ElevateBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ElevateBio's last funding round?
ElevateBio's most recent funding round was Series D on May 24, 2023.
Who are the main investors in ElevateBio?
Key investors in ElevateBio include MPM Capital, MPM BioImpact, EDBI, Invus Opportunities, Matrix Capital Management.
Will ElevateBio IPO soon?
No public IPO plans have been announced for ElevateBio.
How can I track ElevateBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ElevateBio's secondary market activity and sign up for updates.